PARP-inhibition reprograms macrophages toward an anti-tumor phenotype
2022 · Cell Reports · 52 citations
https://doi.org/10.1016/j.celrep.2022.111462
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
6
Papers
373
Citations
5
h-index
5
i10-index
Shizhong Ke is an academic researcher from Beth Israel Deaconess Medical Center. The author has contributed to research in topics: Signaling Pathways in Disease & Peptidase Inhibition and Analysis & Low-power high-performance VLSI design. The author has an h-index of 5, co-authored 6 publications.
Click to start Chat